Annotated Bibliography; Ethics

Running head: ANNOTATED BIBLIOGRAPHY 1

ANNOTATED BIBLIOGRAPHY 2

Annotated Bibliography

Bayer's record fraud. (2003). Multinational Monitor, 24(5), 6. Retrieved from

C:\Users\BBB Gtown\Downloads\ProQuestDocuments-2014-02-28.html

Falit, B. (2005). The path to cheaper and safer drugs: Revamping the pharmaceutical industry in light of GlaxoSmithKline's settlement. The Journal of Law, Medicine & Ethics, 33(1), 174-179. Retrieved from

..\Documents\Falit, Benjamin source.rtf

Greenwood, K. (2011). The ban on "off-label" pharmaceutical promotion: Constitutionally permissible prophylaxis against false or misleading commercial speech? American Journal of Law and Medicine, 37(2), 278-98. Retrieved from

McKenney, D. (2013). Off-label drug promotion and the use of disclaimers*. Texas Law Review, 92(1), 231-252. Retrieved from